Biography

Tyson is Vice President, Head of Partnership Success at Dyno Therapeutics. He leads Dyno’s partnership-centric strategy channeling the platform toward transformative outcomes for patients. Prior to joining Dyno at CRISPR Therapeutics, he applied agile practices to AAV and CAR-T programs, leading to a $175M upfront out-licence to Vertex Pharmaceuticals. Before that, he served in program and alliance management positions at Momenta, Merck & Co, and Cubist. Earlier in his career, he served as an Air Force officer leading multi-disciplinary teams across diverse environments, spanning from nuclear deterrence to research & development. Tyson earned a B.S. in Management from the United States Air Force Academy, and an MBA from Arizona State University’s W. P. Carey School of Business.